Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Hepatitis C - New drugs and treatment prospects.
- M. Zajac, I. Muszalska, A. Sobczak, Adrianna Dadej, Szymon Tomczak, A. Jelińska
- Chemistry, Medicine
- European journal of medicinal chemistry
- 1 March 2019
The molecular targets and chemical structures of drugs used in HCV treatment are reviewed andications and contraindications for anti-HCV drugs are also discussed together with application regimens. Expand
New Molecular Targets of Anticancer Therapy - Current Status and Perspectives.
The paper discusses the molecular targets and chemical structure of target anticancer drugs that have been approved for and currently applied in antineoplastic therapy together with indications and contraindications for their application. Expand
Evaluation of modified vaccinia virus Ankara expressing VP2 protein of infectious bursal disease virus as an immunogen in chickens
- F. Zanetti, M. Zajac, O. Taboga, G. Calamante
- Medicine, Biology
- Journal of veterinary science
- 1 June 2012
A recombinant modified vaccinia Ankara (MVA) virus expressing mature viral protein 2 (VP2) of the infectious bursal disease virus (IBDV) was constructed to develop MVA-based vaccines for poultry. We… Expand
Tuberculosis - present medication and therapeutic prospects.
- Anna Jeliñsk, M. Zajac, Adrianna Dadej, Szymon Tomczak, Małgorzata Geszke-Moritz, I. Muszalska
- Current medicinal chemistry
- 31 January 2020
Despite a 22% decrease in the tuberculosis fatality rate observed between 2000 and 2015, the disease remains one of the ten prime causes of death worldwide and increasing bacterial resistance and expensive, prolonged therapies are the main reasons for efforts to find effective drugs or antituberculotic regimens. Expand